News coverage about Cooper Companies (NYSE:COO) has been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cooper Companies earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned news articles about the medical device company an impact score of 46.0634326873609 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the media stories that may have impacted Accern Sentiment’s analysis:
- Growing Cyberspace Threat Demands Policy Leadership and Cooperation (markets.financialcontent.com)
- Capitol Report: PwC barred from issuing audit opinions in India for two years (marketwatch.com)
- Kansas City Regional Association Of REALTORS® Expand Service Territory With Recent Merger Of St. Joseph Regional Association Of REALTORS® (prweb.com)
- JPEG Inc. Offers the Best Electrical Service in Fort Lauderdale and Plantation Florida Area (releasewire.com)
- Emerson Completes Cooper-Atkins Acquisition (markets.financialcontent.com)
Several equities analysts recently commented on the stock. Zacks Investment Research lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Monday. Oppenheimer set a $250.00 price target on shares of Cooper Companies and gave the stock a “hold” rating in a research report on Friday, December 8th. Stifel Nicolaus reaffirmed a “buy” rating and set a $265.00 price target (down previously from $275.00) on shares of Cooper Companies in a research report on Friday, December 8th. Raymond James Financial reaffirmed a “buy” rating and set a $265.00 price target on shares of Cooper Companies in a research report on Monday, December 4th. Finally, KeyCorp reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, October 20th. Seven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Cooper Companies currently has an average rating of “Buy” and a consensus price target of $259.70.
Cooper Companies (COO) traded up $2.20 during trading on Friday, hitting $230.84. 352,605 shares of the stock traded hands, compared to its average volume of 529,756. Cooper Companies has a 52 week low of $177.06 and a 52 week high of $256.39. The firm has a market capitalization of $11,280.00, a price-to-earnings ratio of 30.70, a P/E/G ratio of 1.86 and a beta of 0.54. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36.
Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The company had revenue of $561.50 million during the quarter, compared to analyst estimates of $558.86 million. During the same quarter in the prior year, the business earned $2.28 earnings per share. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. sell-side analysts forecast that Cooper Companies will post 11.51 earnings per share for the current fiscal year.
The firm also recently disclosed a semiannual dividend, which will be paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd will be given a $0.03 dividend. This represents a dividend yield of 0.03%. The ex-dividend date is Monday, January 22nd. Cooper Companies’s payout ratio is currently 0.80%.
In other news, CEO Robert S. Weiss sold 32,500 shares of the stock in a transaction on Monday, December 18th. The shares were sold at an average price of $224.70, for a total value of $7,302,750.00. Following the completion of the sale, the chief executive officer now owns 119,111 shares of the company’s stock, valued at $26,764,241.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director A Thomas Bender sold 9,150 shares of the stock in a transaction on Monday, December 18th. The stock was sold at an average price of $229.17, for a total transaction of $2,096,905.50. Following the completion of the sale, the director now directly owns 11,205 shares of the company’s stock, valued at approximately $2,567,849.85. The disclosure for this sale can be found here. Insiders sold 47,935 shares of company stock valued at $10,813,768 in the last three months. Company insiders own 1.60% of the company’s stock.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.